Platinum-Resistant Lung Small Cell Carcinoma Active Not Recruiting Phase 2 Trials for Berzosertib (DB11794)

IndicationStatusPhase
DBCOND0118884 (Platinum-Resistant Lung Small Cell Carcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03896503Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the LungsTreatment